Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2004

01-08-2004 | Concise Article

Seroepidemiology of rubella in northern Greece

Authors: G. Gioula, E. Diza-Mataftsi, S. Alexiou-Daniel, V. Kyriazopoulou-Dalaina

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2004

Login to get access

Abstract

In light of two rubella outbreaks in northern Greece during the last decade (1993 and 1999) and periodic changes to the immunization strategy, the present study was conducted to determine the current status of rubella immunity in this region. Among the 729 subjects studied the total vaccination rate was 30.4% and the seroprevalence rate was 82.4% (odds ratio, 0.618; 95% confidence interval, 0.415–0.921). A higher seroprevalence (83.2%) was observed among people born before 1989, when the national rubella immunization program was introduced, compared to the individuals born after 1989 (67.1%; P=0.000). Among women of reproductive age (i.e. 16–40 years), who represented 69.6% of the study population, 10.3% were susceptible to rubella and only 16.4% were vaccinated. The results indicate a comprehensive policy is still needed in order to eliminate rubella and congenital rubella syndrome in Greece.
Literature
1.
go back to reference Cooper LZ (1985) The history and medical consequences of rubella. Rev Infect Dis 7(Suppl 1):2–10 Cooper LZ (1985) The history and medical consequences of rubella. Rev Infect Dis 7(Suppl 1):2–10
2.
go back to reference Miller E, Cradock-Watson JE, Pollock TM (1982) Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 2:781–784 Miller E, Cradock-Watson JE, Pollock TM (1982) Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 2:781–784
3.
go back to reference Miller C, Miller E, Sequeira P et al (1985) Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J 291:1398–1401 Miller C, Miller E, Sequeira P et al (1985) Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J 291:1398–1401
4.
go back to reference Panagiotopoulos T, Antoniadou I, Valassi-Adam E (1999) Increase in congenital rubella occurrence after immunization in Greece: retrospective survey and systematic review. Br Med J 319:1462–1467 Panagiotopoulos T, Antoniadou I, Valassi-Adam E (1999) Increase in congenital rubella occurrence after immunization in Greece: retrospective survey and systematic review. Br Med J 319:1462–1467
5.
go back to reference Tsagaropoulou-Stigga H (2000) The MMR vaccine. Vaccines in Greece. Hellenic Pediatric Society, Thessaloniki Tsagaropoulou-Stigga H (2000) The MMR vaccine. Vaccines in Greece. Hellenic Pediatric Society, Thessaloniki
7.
go back to reference Keramida-Karamitsou P, Edipidis T (1972) Frequency of rubella antibodies among children 5–12 years old. Acta Microbiologica Hellenica 17:109–115 Keramida-Karamitsou P, Edipidis T (1972) Frequency of rubella antibodies among children 5–12 years old. Acta Microbiologica Hellenica 17:109–115
8.
go back to reference Keramida-Karamitsou P (1971) The importance of detecting antibodies against rebella virus in females. Thesis. Aristotle University of Thessaloniki (in Greek) Keramida-Karamitsou P (1971) The importance of detecting antibodies against rebella virus in females. Thesis. Aristotle University of Thessaloniki (in Greek)
9.
go back to reference Andrews N et al (2000) The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 125:127–141 Andrews N et al (2000) The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 125:127–141
10.
go back to reference Kyriazopoulou V, Frantzidou F, Diza E, Souliou E (1995) Recent techniques used for rubella diagnosis. Progress or confusion? Acta Microbiologica Hellenica 40:34–39 Kyriazopoulou V, Frantzidou F, Diza E, Souliou E (1995) Recent techniques used for rubella diagnosis. Progress or confusion? Acta Microbiologica Hellenica 40:34–39
11.
go back to reference Centers for Disease Control (1970) Standard rubella haemagglutination inhibition test. US Public Health Service, Washington DC, Publication number 17 Centers for Disease Control (1970) Standard rubella haemagglutination inhibition test. US Public Health Service, Washington DC, Publication number 17
12.
go back to reference Panagiotopoulos T, Antoniadou I, Antonopoulou E et al (1996) Increase of age at infection in Attiki (Greece) during the rubella epidemic of 1993. Arch Hellenic Med 13:211–219 Panagiotopoulos T, Antoniadou I, Antonopoulou E et al (1996) Increase of age at infection in Attiki (Greece) during the rubella epidemic of 1993. Arch Hellenic Med 13:211–219
Metadata
Title
Seroepidemiology of rubella in northern Greece
Authors
G. Gioula
E. Diza-Mataftsi
S. Alexiou-Daniel
V. Kyriazopoulou-Dalaina
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2004
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1172-y

Other articles of this Issue 8/2004

European Journal of Clinical Microbiology & Infectious Diseases 8/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine